Bispecific CAR T-cell therapy: combining anti-CD19 and CD22 CAR T-cells
Developments in therapies for AML - chemotherapy, targeted therapy and immunotherapy
Hagop M. Kantarjian
Allogeneic transplant is not the quintessential treatment for ALL anymore!
Novel therapies in myeloma: selinexor, venetoclax, among others
Heinz Ludwig et al.
Precision medicine for MDS, what drugs for which patients?